SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing a massive parabolic rally driven by an extremely low float, intense short-squeeze dynamics, and significant speculation regarding its pivot from cannabis to telecommunications infrastructure in Mexico. The community is heavily focused on the high cost-to-borrow rates and the potential for a continued squeeze, leading to heated debates between bullish traders capitalizing on the momentum and skeptical observers warning of potential dilution and volatility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending as investors debate whether the stock represents a deep-value opportunity following its recent reorganization into three standalone business units, including a separate segment for Venmo. While some market participants are optimistic that these structural changes and potential strategic flexibility will unlock significant shareholder value, others remain skeptical, pointing to persistent competitive pressures and the stock's long-term underperformance.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing heightened market scrutiny ahead of its earnings report as investors debate the impact of significant capital expenditure and dilution risks against the potential growth catalyst of the R2 platform. While some community members remain optimistic about long-term production scaling and the company's strategic partnerships, others are concerned about cash burn, share dilution, and executive compensation packages amidst a volatile electric vehicle market.

The White Alien has arrived. The countdown to domination starts now.

The White Alien

The White Alien is generating buzz through aggressive social media cross-promotion with various other memecoins, sparking intense community debate between optimistic traders betting on rapid price momentum and skeptics questioning the token's long-term legitimacy.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is seeing heightened volatility and intense social media debate after a sharp decline in share price triggered concerns regarding slowing user engagement and long-term monetization. The community is deeply divided between long-term investors highlighting strong free cash flow and persistent growth, and vocal critics pointing to unresolved safety concerns and a challenging regulatory environment for youth-oriented platforms.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently surging on the strength of back-to-back mission successes and an aggressive launch cadence, with the community closely tracking its growing role in defense contracts and space infrastructure. Investors are highly optimistic about the stock's potential for triple-digit growth, driven by institutional confidence, anticipation of upcoming earnings, and the company's status as a key infrastructure player alongside SpaceX.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is generating renewed buzz as the community closely watches critical resistance levels, with many speculating that a breakout could trigger a significant upward trend. Investors are actively debating the token's potential to lead a broader crypto rally, balancing optimism regarding its long-term utility against frustrations over recent price consolidation.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is currently experiencing extreme volatility and heavy volume as traders react to a recent preclinical milestone payment and an upcoming R&D presentation, while others express deep skepticism regarding the company's long-term performance and potential reverse split. The community is sharply divided, with bulls pointing to fundamental technology developments and Big Pharma partnerships, while bears highlight persistent dilution, management concerns, and a downward trend in share price.

Alchemy Pay

Alchemy Pay is capturing significant community attention as investors debate its transition toward a Layer 1 blockchain and expansion of its fiat-to-crypto payment infrastructure. While some traders are bullish on new regulatory licensing and upcoming mainnet developments, others are actively debating concerns regarding token supply inflation and the project's long-term competitive moat against other payment solutions.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heightened market attention driven by its strategic role in domestic critical mineral supply chains, with community discourse heavily focused on government defense contracts and the impact of ongoing geopolitical trade restrictions. Investors are actively debating the timing of potential catalysts, with many closely monitoring technical chart patterns and volume spikes as indicators of a possible sustained trend or short-term breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zura Bio (ZURA) to Release Earnings on Thursday

Zura Bio (NASDAQ:ZURA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-zura-bio-limited-stock...

Zura Bio (NASDAQ:ZURA) Shares Down 5.3% - Time to Sell?

Zura Bio (NASDAQ:ZURA) Shares Down 5.3% - Here's What Happened...

Zura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of "Moderate Buy" by Analysts

Zura Bio Limited (NASDAQ:ZURA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six brokerages that are currently covering the stock, Marketbeat.com reports. One...

Zura Bio (NASDAQ:ZURA)  Shares Down 6.5%   - Here's What Happened

Zura Bio (NASDAQ:ZURA) Shares Down 6.5% - Here's What Happened...

Zura Bio (ZURA) Projected to Post Quarterly Earnings on Wednesday

Zura Bio (NASDAQ:ZURA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-1-zura-bio-limited-stock...

Zura Bio (NASDAQ:ZURA) Price Target Raised to $11.00

Chardan Capital increased their price target on Zura Bio from $10.00 to $11.00 and gave the stock a "buy" rating in a report on Monday...

Zura Bio (NASDAQ:ZURA) Given New $15.00 Price Target at Oppenheimer

Oppenheimer lowered their target price on shares of Zura Bio from $16.00 to $15.00 and set an "outperform" rating for the company in a research note on Friday...

Zura Bio Limited (NASDAQ:ZURA) Given Average Recommendation of "Moderate Buy" by Analysts

Zura Bio Limited (NASDAQ:ZURA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven research firms that are currently covering the stock, Marketbeat Ratings...

Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates

Zura Bio Limited (Nasdaq: ZURA) (Zura), a clinicalstage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating...

Boothbay Fund Management LLC Acquires New Shares in Zura Bio Limited $ZURA

Boothbay Fund Management LLC acquired a new position in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing...

Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.17	--	--	N/A
Q4 '25	-$0.20	-$0.49	-149.68%	MISSED
Q3 '25	-$0.19	-$0.21	-9.80%	MISSED
Q2 '25	-$0.19	-$0.17	9.73%	BEAT
Q1 '25	-$0.16	-$0.19	-19.82%	MISSED

ZURA
Zura Bio Ltd - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ZURA News

ZURAZura Bio Ltd - Ordinary Shares - Class A